Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue
January 14, 2025 16:15 ET
|
Rapid Micro Biosystems, Inc.
Fourth quarter 2024 total revenue expected to be a record at approximately $8.2 million, representing growth of approximately 30% compared to the prior-year period. Fourth quarter 2024 recurring...
Rapid Micro Biosystems to Present at 43ʳᵈ Annual J.P. Morgan Healthcare Conference
January 07, 2025 16:05 ET
|
Rapid Micro Biosystems, Inc.
LEXINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference
November 08, 2024 08:00 ET
|
Rapid Micro Biosystems, Inc.
LEXINGTON, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results
November 01, 2024 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports record third quarter 2024 revenue of $7.6 million, representing growth of 24% compared to the third quarter of 2023Placed seven Growth Direct® systems in the third quarter of 2024, marking the...
Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024
October 23, 2024 16:45 ET
|
Rapid Micro Biosystems, Inc.
LEXINGTON, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation...
Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
September 03, 2024 16:50 ET
|
Rapid Micro Biosystems, Inc.
LEXINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results
August 02, 2024 07:00 ET
|
Rapid Micro Biosystems, Inc.
Record second quarter 2024 revenue of $6.6 million, representing growth of 32% compared to the second quarter of 2023150th Growth Direct® system placed with an existing top 15 global pharma customer...
Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024
July 17, 2024 16:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation...
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
May 03, 2024 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports first quarter 2024 total revenue of $5.6 million, representing growth of 11% compared to first quarter 2023 Reaffirms full year 2024 total revenue guidance of at least $27.0 million,...
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024
April 18, 2024 16:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation...